Diagnostics and research stocks

Companies

74

Combined market cap

$962.7B

Median PE

39.4×

Median revenue growth

+4.9%

Median net margin

−5.0%

Company	Market cap	PE	P/S	Revenue growth	Net margin	Dividend yield
TMOThermo Fisher Scientificcaveat	$249.1B	35.5×	5.3×	+8%	14.9%	0.27%
DHRDanaher	$162B	40.9×	6.5×	+5%	15.9%	0.66%
NTRANatera	$58.2B	n/m	21.5×	+38%	−7.1%	n/m
AAgilent Technologies	$48.8B	34.0×	6.6×	+9%	19.5%	0.59%
IQVIQVIA	$46B	34.7×	2.7×	+8%	8.1%	n/m
WATWaters	$44.6B	113×	9.6×	+52%	3.6%	n/m
IDXXIDEXX Laboratories	$44.1B	39.4×	9.7×	+13%	25.0%	n/m
ILMNIllumina	$40.7B	50.1×	9.1×	+5%	18.4%	n/m
MTDMettler-Toledo International	$33.5B	37.6×	8.1×	+7%	21.9%	n/m
DGXQuest Diagnostics	$26.7B	25.7×	2.3×	+9%	9.2%	1.40%
LHLabcorp	$26.7B	27.2×	1.9×	+6%	7.0%	0.88%
GHGuardant Health	$22.7B	n/m	19.2×	+43%	−38.3%	n/m
MEDPMedpace	$18.7B	39.2×	6.7×	+25%	17.7%	n/m
RVTYRevvity	$17.7B	75.6×	6.1×	+4%	8.2%	n/m
CRLCharles River Laboratories International	$16.5B	n/m	4.1×	−1%	−6.0%	n/m
AVTRAvantor	$11.7B	n/m	1.8×	−2%	−8.8%	n/m
BIOBio-Rad Laboratories	$9.9B	44.8×	3.8×	+1%	8.6%	n/m
TXG10x Genomics	$9.3B	n/m	15.1×	−4%	−12.2%	n/m
CAICaris Life Sciences	$9B	86.5×	9.1×	+85%	10.6%	n/m
BRKRBruker	$8.8B	n/m	2.5×	+2%	−2.0%	n/m
LNTHLantheus	$6.5B	24.2×	4.2×	+2%	17.7%	n/m
GRALGRAIL	$5.9B	n/m	35.8×	+23%	n/m	n/m
RDNTRadNet	$5.5B	n/m	2.4×	+19%	−0.9%	n/m
BLLNBillionToOnecaveat	$5.1B	166×	12.8×	+90%	9.5%	n/m
VCYTVeracyte	$3.9B	34.2×	6.9×	+17%	20.4%	n/m
CDNACareDxcaveat	$3.6B	33.4×	7.8×	+34%	24.2%	n/m
CELCCelcuity	$3.2B	n/m	n/m	n/m	n/m	n/m
NEOGNeogen	$2.7B	n/m	3.0×	−0%	−6.3%	n/m
CLDXCelldex Therapeutics	$2.3B	n/m	n/m	−97%	n/m	n/m
FTREFortreacaveat	$2.2B	n/m	0.8×	−2%	−3.2%	n/m
ALMRAlamar Biosciencescaveat	$2.1B	n/m	n/m	n/m	n/m	n/m
PSNLPersonalis	$1.7B	n/m	24.3×	−13%	n/m	n/m
ABSIAbsci	$1.6B	n/m	n/m	−62%	n/m	n/m
NTLAIntellia Therapeutics	$1.6B	n/m	26.4×	+13%	n/m	n/m
LMRILumexa Imagingcaveat	$1.1B	n/m	n/m	n/m	n/m	n/m
CSTLCastle Biosciences	$1B	n/m	2.8×	+3%	−5.4%	n/m
QDELQuidelOrtho	$941.5M	n/m	0.4×	−2%	−39.2%	n/m
CTKBCytek Biosciences	$726.6M	n/m	3.5×	+5%	−39.0%	n/m
OABIOmniAb	$677.5M	n/m	17.6×	+67%	n/m	n/m
ACHVAchieve Life Sciences	$667.8M	n/m	n/m	n/m	n/m	n/m
PACBPacific Biosciences of California	$655.9M	n/m	4.1×	+2%	−82.5%	n/m
MYGNMyriad Genetics	$556.7M	n/m	0.7×	−3%	−14.0%	n/m
FLGTFulgent Genetics	$553.1M	n/m	1.7×	+7%	−26.0%	n/m
NRCNRC Health	$485.1M	87.7×	3.5×	−0%	4.2%	n/m
MASS908 Devices	$474.9M	n/m	7.8×	+13%	−57.0%	n/m
NAUTNautilus Biotechnologycaveat	$412.3M	n/m	n/m	n/m	n/m	n/m
TKNOAlpha Teknova	$344.7M	n/m	7.9×	+12%	−38.4%	n/m
BDSXBiodesix	$223.5M	n/m	2.2×	+34%	−27.0%	n/m
XGNExagen	$176.1M	n/m	2.5×	+21%	−26.6%	n/m
MXCTMaxcyte	$144.5M	n/m	4.7×	−13%	n/m	n/m
QTRXQuanterix	$135.3M	n/m	0.9×	+22%	−80.2%	n/m
FRNMFreenomecaveat	$131.7M	n/m	n/m	n/m	n/m	n/m
SEERSeer	$109.1M	n/m	7.7×	−13%	n/m	n/m
ICCCImmucell	$93.1M	128×	3.0×	+8%	2.6%	n/m
IMDXInsight Molecular Diagnostics	$92.6M	n/m	55.5×	−61%	n/m	n/m
SERASera Prognostics	$80.1M	n/m	n/m	−35%	n/m	n/m
IBACIB Acquisition	$54.4M	n/m	n/m	n/m	n/m	n/m
RPIDRapid Micro Biosystems	$39.1M	n/m	1.1×	+16%	n/m	n/m
HBIOHarvard Bioscience	$37.5M	n/m	0.4×	−1%	−11.9%	n/m
PRPOPrecipio	$35.8M	n/m	1.3×	+28%	−4.5%	n/m
EYPTEyePoint	$34.9M	n/m	12.5×	−95%	n/m	n/m
ONMDOneMedNet	$27.9M	n/m	19.2×	+217%	n/m	n/m
BNGOBionano Genomics	$13.3M	n/m	0.4×	+10%	n/m	n/m
ASTCASTROTECH	$10.1M	n/m	11.1×	−13%	n/m	n/m
AMSAmerican Shared Hospital Services	$8.4M	n/m	0.3×	+4%	−5.8%	n/m
BMRABiomerica	$7.7M	n/m	1.8×	−11%	n/m	n/m
ACONAclarioncaveat	$5.6M	n/m	66.4×	+33%	n/m	n/m
ADVBAdvanced Biomedcaveat	$5.2M	n/m	n/m	n/m	n/m	n/m
CDIOCardio Diagnostics	$5M	n/m	n/m	−26%	n/m	n/m
QCLSQ/C Technologies	$3.9M	n/m	n/m	n/m	n/m	n/m
BGLCBioNexus Gene Lab	$3.5M	n/m	1.1×	−67%	−82.4%	n/m
VNRXVolitionrx	$2.4M	n/m	1.0×	+86%	n/m	n/m
ISPCiSpecimencaveat	$2.1M	n/m	4.4×	−92%	n/m	n/m
BIAFbioAffinity Technologies	$1.5M	n/m	0.3×	−23%	n/m	n/m

Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.